Trial Profile
A single-center, ADME study of Siponimod in healthy volunteer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 15 May 2018
Price :
$35
*
At a glance
- Drugs Siponimod (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacokinetics
- 15 May 2018 New trial record
- 07 May 2018 Results published in the Drug Metabolism and Disposition